Abstract
Leishmaniases refer to a group of diseases caused by parasites of the Leishmania genus, which mainly affect people in a social vulnerability state. Currently, the drugs available for the treatment of leishmaniasis contribute to the appearance of other clinical comorbidities due to their side effects, which does the search for new therapeutic targets fundamental. In model eukaryotes, inosi…